[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100511179":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":27,"responsibleParty":45,"collaborators":7,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":7,"enrollmentInfo":56,"targetDuration":7,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"University Hospital, Limoges","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Patients co-infected HBV\u002FHDV","Step 1: collection of SNDS data from 2016 to 2020 Snapshot of the prescription of the Delta tests and the tests usually prescribed simultaneously (HBV but also HIV and HCV) in one year. The investigator will collect the number of tests performed once for a given patient: anti-HDV, HDV RNA, HBsAg, anti-HCV, anti-HIV, and for each test, the description of the profile and the geographical distribution of prescribers in the metropolitan area; the description of age and sex of the patients screened. Step 2: collection of anti-HDV and RNA tests performed in French private and Public laboratories over the year 2019 Anti-HDV and HDV RNA are subcontracted by most private laboratories to two specialized biology companies. Number of HDV tests prescribed, technique used, number of positive tests and name of the requesting laboratory will be collected. The investigator will then go back to the prescriber of the positive tests, identify the patient, his epidemiological profile and his medical care.",[14],{"name":15,"affiliation":5,"role":16},"Véronique Loustaud-Ratti, Pr","PRINCIPAL_INVESTIGATOR",[18,24],{"name":19,"role":20,"phone":21,"phoneExt":22,"email":23},"Sandra Juge","CONTACT","0555056414","33","Sandra.Juge@chu-limoges.fr",{"name":25,"role":20,"phone":7,"phoneExt":7,"email":26},"Céline Rigaud","celine.rigaud@chu-limoges.fr",[28],{"facility":29,"status":30,"city":31,"state":7,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Chu Limoges","RECRUITING","Limoges","87042","France","FR",{"type":36,"coordinates":37},"Point",[38,39],1.24759,45.83362,{"lat":39,"lon":38},[42,43],{"name":19,"role":20,"phone":21,"phoneExt":22,"email":23},{"name":44,"role":16,"phone":7,"phoneExt":7,"email":7},"Véronique LOUSTAUD-RATTI, Pr",{"type":46,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100511179","delta-describe-the-french-collaborative-project-100511179",false,"NCT05936073","DELTA DESCRIBE: the French Collaborative Project","DELTADESCRIBE","Inclusion Criteria:\n\n* \\>18 years at the second step\n* HDV RNA positive patients identified at the second step\n* Patients non opposed to the collection of their data\n\nExclusion Criteria:\n\n* Opposition expressed by the patients for the collection of their data","ALL","18 Years",{"count":57,"type":58},734,"ESTIMATED","OBSERVATIONAL","Our global objective is to draw up a photograph of HDV patients over one year in metropolitan France and identify the barriers of screening and care. The investigator suspects a mismatch between HBV and HDV screening, the first step for specialized care pathway in metropolitan France.",[62],"Hepatitis D",[64,65,66,67],"HBs Ag","Delta hepatitis","Screening","Reflex testing","2025-05-24",{"date":70,"type":71},"2025-05-28","ACTUAL",{"date":73,"type":71},"2024-01-22",{"date":75,"type":58},"2025-06-22",{"name":5,"class":6},1]